Invention Grant
- Patent Title: Uracil compound as c-MET/AXL inhibitor
-
Application No.: US16766510Application Date: 2018-11-23
-
Publication No.: US11623923B2Publication Date: 2023-04-11
- Inventor: Jinping Li , Xiongbin Xu , Gang Li , Lihong Hu , Charles Z. Ding , Yaling Zhou , Guoping Hu , Jian Li , Shuhui Chen
- Applicant: MEDSHINE DISCOVERY, INC.
- Applicant Address: CN Jiangsu
- Assignee: MEDSHINE DISCOVERY, INC.
- Current Assignee: MEDSHINE DISCOVERY, INC.
- Current Assignee Address: CN Jiangsu
- Agency: McDermott Will & Emery LLP
- Priority: CN201711190571.6 20171124,CN201811159913.2 20180930
- International Application: PCT/CN2018/117269 WO 20181123
- International Announcement: WO2019/101178 WO 20190531
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D401/14 ; A61P35/00 ; C07D405/14 ; C07D487/04
Abstract:
Provided are a uracil compound represented by Formula (IV) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition of the same. Also provided is a use thereof as a c-MET/AXL inhibitor in preparing a c-MET/AXL-inhibiting drug or a drug for treating a tumor.
Public/Granted literature
- US20210371395A1 URACIL COMPOUND AS C-MET/AXL INHIBITOR Public/Granted day:2021-12-02
Information query
